-
PSMA PET and Functional Imaging - 2021 Prostate Cancer Patient Conference
The California Prostate Cancer Coalition (CPCC) and The Helen Family Diller Comprehensive Cancer Center present the 2021 Patient Conference on Prostate Cancer. This session: Tom Hope, MD, UCSF. Recorded on 05/14/2021. [Show ID: 37268]
Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.
More from: Prostate Cancer Patient Conference
(https://www.uctv.tv/prostate-cancer-conference)
Explore More Health & Medicine on UCTV
(https://www.uctv.tv/health)
UCTV features the latest in health and medicine from University of California medical schools. Find the information you need on cancer, transplantation, obesity, disease and much more.
UCTV is the broadcast and online media platform of the University of California, featuring programm...
published: 28 Jul 2021
-
PSMA & Newly-Diagnosed #ProstateCancer | MarkScholzMD #AlexScholz #PCRI
Donate to PCRI: https://pcri.org/donate
For more information. visit www.pcri.org
0:48 What is a PSMA scan and what is it used for?
1:51 What are 3T and 1.5T MRI's?
3:00 Can PSMA scans be used to guide targeted biopsies?
3:50 Are PSMA scans ever approved for early stage disease?
5:13 Are there situations when a 3T MRI is used instead of PSMA?
7:47 Can PSMA scans be used to shorten the course of hormone therapy?
10:15 Do patients ever forego hormone therapy after a PSMA scan?
11:29 How is PSMA monitored in someone foregoing hormone therapy?
12:50 What exactly does it mean to be "cured" of prostate cancer?
13:36 Do PSMA scans work for every patient?
14:43 Can those who PSMA doesn't work still forego hormone therapy?
16:28 Alex's conclusion
Don't know your stage? Take ...
published: 13 Oct 2023
-
PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022
Geoffrey Johnson, MD, Ph.D., is a radiologist specializing in nuclear medicine at the Mayo Clinic in Rochester, Minnesota. Here, he discusses PET/CT scans and new "theranostics" treatments for prostate cancer, including the newly approved "Pluvicto" (lutetium-177). Theranostics is a combination of "therapy" and "diagnostics". It refers to the fact that the same radiotracer used for the PET scan ("PSMA" in the case of Pluvicto) is used to guide injectible radioactive particles to the sites of disease. View Dr. Johnson's faculty page here: https://www.mayoclinic.org/biographies/johnson-geoffrey-b-m-d-ph-d/bio-20055408
Get the full conference experience here: https://pcri.org/2022-conference
Watch Day 1 of the 2022 September Conference here: https://youtu.be/8Vdet74V-j8
Day 1 features the f...
published: 10 Oct 2022
-
PSMA Imaging & the Potential Role of PSMA Radioguided Surgery | Robert Reiter, MD, MBA | UCLA Health
Join Robert Reiter, MD, MBA, Professor of Urology and Chief of the Division of Urologic Oncology at UCLA, to learn more about a new program using the most advanced forms of molecular imaging of prostate cancer to help guide the surgical removal of any sites of metastatic disease.
published: 10 Oct 2022
-
How PSMA Revolutionizes Staging for #prostatecancer | #markscholzmd | #PCRI
The sensitivity and specificity of the PSMA PET scan makes it one of the most important developments in the history of prostate cancer management. However, its use in the United States is still not universal for men diagnosed with prostate cancer. Moreover, since the scan has just now become widely available, it could be many years before studies are completed that will determine how, exactly, physicians should interpret and act on the new information it has made available. For example, can a newly diagnosed man with Gleason 8 prostate cancer reduce the duration of hormone therapy if he has a negative PSMA PET scan, or is the negative scan a false sense of security? Here, Dr. Scholz--a medical oncologist specializing in the treatment of prostate cancer--explains how we can think about thi...
published: 09 Jan 2023
-
PSMA/PET Imaging for Prostate Cancer
Welcome to the 2023 ZERO Prostate Cancer Summit! In this segment, hear about PSMA/PET imaging for prostate cancer from Dr. Daneil Kuftinec.
For more information on ZERO Prostate Cancer, visit zerocancer.org.
published: 14 Mar 2023
-
How PSMA Can Change Treatment Decisions for Prostate Cancer | Mark Moyad, MD, MPH & Mark Scholz, MD
Watch the entire 2021 Mid-Year Update here: https://youtu.be/mQzpdvLBeVM
Drs. Mark Scholz and Mark Moyad discuss the implications of the recently approved PSMA PET scan in the management of prostate cancer.
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the di...
published: 26 Apr 2021
-
2021: PSMA and Prostate Imaging | Dr. Thomas Hope | 2021 Moyad + Scholz Mid-Year Update | PCRI
Watch the entire 2021 Mid-Year Update here: https://youtu.be/mQzpdvLBeVM
Radiologist and nuclear medicine expert, Thomas Hope, MD gives a survey of the imaging modalities being used in the management of prostate cancer with an emphasis on the PSMA PET scan which was recently FDA-approved thanks in large part to the efforts of Dr. Hope at the University of California, San Francisco.
Thomas Hope, MD, is the Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. He also serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center.
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Who we are:
The Prostat...
published: 02 Apr 2021
-
What is PSMA-PET Scan Radioactive Imaging?
Discover the miracle of PSMA-PET scans. PSMA-PET Scan Radioactive Imaging is the cutting edge in detecting cancer. This video features world-class doctors and researchers discussing this amazing cancer detecting scan.
Featuring Thomas Hope, MD, Kenneth J. Pienta, MD, and Neil H. Bander, MD
published: 01 Dec 2020
-
Detecting prostate cancer with PSMA PET
A new imaging method called the prostate specific membrane antigen PET scan helps physicians detect more prostate cancer cells so they can be treated. When David McEowen discovered he had a recurrence of prostate cancer, his physicians used PSMA PET as part of his treatment plan. Today, David is cancer-free.
published: 01 Dec 2020
12:25
PSMA PET and Functional Imaging - 2021 Prostate Cancer Patient Conference
The California Prostate Cancer Coalition (CPCC) and The Helen Family Diller Comprehensive Cancer Center present the 2021 Patient Conference on Prostate Cancer. ...
The California Prostate Cancer Coalition (CPCC) and The Helen Family Diller Comprehensive Cancer Center present the 2021 Patient Conference on Prostate Cancer. This session: Tom Hope, MD, UCSF. Recorded on 05/14/2021. [Show ID: 37268]
Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.
More from: Prostate Cancer Patient Conference
(https://www.uctv.tv/prostate-cancer-conference)
Explore More Health & Medicine on UCTV
(https://www.uctv.tv/health)
UCTV features the latest in health and medicine from University of California medical schools. Find the information you need on cancer, transplantation, obesity, disease and much more.
UCTV is the broadcast and online media platform of the University of California, featuring programming from its ten campuses, three national labs and affiliated research institutions. UCTV explores a broad spectrum of subjects for a general audience, including science, health and medicine, public affairs, humanities, arts and music, business, education, and agriculture. Launched in January 2000, UCTV embraces the core missions of the University of California -- teaching, research, and public service – by providing quality, in-depth television far beyond the campus borders to inquisitive viewers around the world.
(https://www.uctv.tv)
https://wn.com/Psma_Pet_And_Functional_Imaging_2021_Prostate_Cancer_Patient_Conference
The California Prostate Cancer Coalition (CPCC) and The Helen Family Diller Comprehensive Cancer Center present the 2021 Patient Conference on Prostate Cancer. This session: Tom Hope, MD, UCSF. Recorded on 05/14/2021. [Show ID: 37268]
Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.
More from: Prostate Cancer Patient Conference
(https://www.uctv.tv/prostate-cancer-conference)
Explore More Health & Medicine on UCTV
(https://www.uctv.tv/health)
UCTV features the latest in health and medicine from University of California medical schools. Find the information you need on cancer, transplantation, obesity, disease and much more.
UCTV is the broadcast and online media platform of the University of California, featuring programming from its ten campuses, three national labs and affiliated research institutions. UCTV explores a broad spectrum of subjects for a general audience, including science, health and medicine, public affairs, humanities, arts and music, business, education, and agriculture. Launched in January 2000, UCTV embraces the core missions of the University of California -- teaching, research, and public service – by providing quality, in-depth television far beyond the campus borders to inquisitive viewers around the world.
(https://www.uctv.tv)
- published: 28 Jul 2021
- views: 23349
18:26
PSMA & Newly-Diagnosed #ProstateCancer | MarkScholzMD #AlexScholz #PCRI
Donate to PCRI: https://pcri.org/donate
For more information. visit www.pcri.org
0:48 What is a PSMA scan and what is it used for?
1:51 What are 3T and 1.5T...
Donate to PCRI: https://pcri.org/donate
For more information. visit www.pcri.org
0:48 What is a PSMA scan and what is it used for?
1:51 What are 3T and 1.5T MRI's?
3:00 Can PSMA scans be used to guide targeted biopsies?
3:50 Are PSMA scans ever approved for early stage disease?
5:13 Are there situations when a 3T MRI is used instead of PSMA?
7:47 Can PSMA scans be used to shorten the course of hormone therapy?
10:15 Do patients ever forego hormone therapy after a PSMA scan?
11:29 How is PSMA monitored in someone foregoing hormone therapy?
12:50 What exactly does it mean to be "cured" of prostate cancer?
13:36 Do PSMA scans work for every patient?
14:43 Can those who PSMA doesn't work still forego hormone therapy?
16:28 Alex's conclusion
Don't know your stage? Take the quiz: visit http://www.prostatecancerstaging.org
To learn more about prostate cancer, visit http://www.pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
https://wn.com/Psma_Newly_Diagnosed_Prostatecancer_|_Markscholzmd_Alexscholz_Pcri
Donate to PCRI: https://pcri.org/donate
For more information. visit www.pcri.org
0:48 What is a PSMA scan and what is it used for?
1:51 What are 3T and 1.5T MRI's?
3:00 Can PSMA scans be used to guide targeted biopsies?
3:50 Are PSMA scans ever approved for early stage disease?
5:13 Are there situations when a 3T MRI is used instead of PSMA?
7:47 Can PSMA scans be used to shorten the course of hormone therapy?
10:15 Do patients ever forego hormone therapy after a PSMA scan?
11:29 How is PSMA monitored in someone foregoing hormone therapy?
12:50 What exactly does it mean to be "cured" of prostate cancer?
13:36 Do PSMA scans work for every patient?
14:43 Can those who PSMA doesn't work still forego hormone therapy?
16:28 Alex's conclusion
Don't know your stage? Take the quiz: visit http://www.prostatecancerstaging.org
To learn more about prostate cancer, visit http://www.pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
- published: 13 Oct 2023
- views: 16483
1:10:05
PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022
Geoffrey Johnson, MD, Ph.D., is a radiologist specializing in nuclear medicine at the Mayo Clinic in Rochester, Minnesota. Here, he discusses PET/CT scans and n...
Geoffrey Johnson, MD, Ph.D., is a radiologist specializing in nuclear medicine at the Mayo Clinic in Rochester, Minnesota. Here, he discusses PET/CT scans and new "theranostics" treatments for prostate cancer, including the newly approved "Pluvicto" (lutetium-177). Theranostics is a combination of "therapy" and "diagnostics". It refers to the fact that the same radiotracer used for the PET scan ("PSMA" in the case of Pluvicto) is used to guide injectible radioactive particles to the sites of disease. View Dr. Johnson's faculty page here: https://www.mayoclinic.org/biographies/johnson-geoffrey-b-m-d-ph-d/bio-20055408
Get the full conference experience here: https://pcri.org/2022-conference
Watch Day 1 of the 2022 September Conference here: https://youtu.be/8Vdet74V-j8
Day 1 features the following lectures & Q&A sessions:
"PSMA PET, Theranostics, SPECT, and the Road Ahead in Prostate Cancer" by Geoffrey Johnson, MD, Ph.D
"Improving Quality of Life: ED, Incontinence, and More" by Jeffrey Brady, MD, FACS
"Active Surveillance Update 2022" by Laurence Klotz, CM, MD
Watch Day 2 of the 2022 September Conference here: https://youtu.be/8ToGNIyTNB0
Day 2 features the following lectures and Q&A sessions:
"2022 Hot Topics in Advanced Prostate Cancer" by Evan Yu, MD
"DIY Combat Manual for Beating Prostate Cancer" by Eugene Kwon, MD
"Conference Wrap Up" with Mark Moyad, MD, MPH, and Mark Scholz, MD
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #GeoffreyJohnsonMD #PCRI
https://wn.com/Psma_Scans_Pluvicto_(Lutetium_177)_In_2022_|_Geoffrey_Johnson,_Md,_Phd_|_Pcri_Conference_2022
Geoffrey Johnson, MD, Ph.D., is a radiologist specializing in nuclear medicine at the Mayo Clinic in Rochester, Minnesota. Here, he discusses PET/CT scans and new "theranostics" treatments for prostate cancer, including the newly approved "Pluvicto" (lutetium-177). Theranostics is a combination of "therapy" and "diagnostics". It refers to the fact that the same radiotracer used for the PET scan ("PSMA" in the case of Pluvicto) is used to guide injectible radioactive particles to the sites of disease. View Dr. Johnson's faculty page here: https://www.mayoclinic.org/biographies/johnson-geoffrey-b-m-d-ph-d/bio-20055408
Get the full conference experience here: https://pcri.org/2022-conference
Watch Day 1 of the 2022 September Conference here: https://youtu.be/8Vdet74V-j8
Day 1 features the following lectures & Q&A sessions:
"PSMA PET, Theranostics, SPECT, and the Road Ahead in Prostate Cancer" by Geoffrey Johnson, MD, Ph.D
"Improving Quality of Life: ED, Incontinence, and More" by Jeffrey Brady, MD, FACS
"Active Surveillance Update 2022" by Laurence Klotz, CM, MD
Watch Day 2 of the 2022 September Conference here: https://youtu.be/8ToGNIyTNB0
Day 2 features the following lectures and Q&A sessions:
"2022 Hot Topics in Advanced Prostate Cancer" by Evan Yu, MD
"DIY Combat Manual for Beating Prostate Cancer" by Eugene Kwon, MD
"Conference Wrap Up" with Mark Moyad, MD, MPH, and Mark Scholz, MD
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #GeoffreyJohnsonMD #PCRI
- published: 10 Oct 2022
- views: 44891
17:44
PSMA Imaging & the Potential Role of PSMA Radioguided Surgery | Robert Reiter, MD, MBA | UCLA Health
Join Robert Reiter, MD, MBA, Professor of Urology and Chief of the Division of Urologic Oncology at UCLA, to learn more about a new program using the most advan...
Join Robert Reiter, MD, MBA, Professor of Urology and Chief of the Division of Urologic Oncology at UCLA, to learn more about a new program using the most advanced forms of molecular imaging of prostate cancer to help guide the surgical removal of any sites of metastatic disease.
https://wn.com/Psma_Imaging_The_Potential_Role_Of_Psma_Radioguided_Surgery_|_Robert_Reiter,_Md,_Mba_|_Ucla_Health
Join Robert Reiter, MD, MBA, Professor of Urology and Chief of the Division of Urologic Oncology at UCLA, to learn more about a new program using the most advanced forms of molecular imaging of prostate cancer to help guide the surgical removal of any sites of metastatic disease.
- published: 10 Oct 2022
- views: 2442
14:09
How PSMA Revolutionizes Staging for #prostatecancer | #markscholzmd | #PCRI
The sensitivity and specificity of the PSMA PET scan makes it one of the most important developments in the history of prostate cancer management. However, its ...
The sensitivity and specificity of the PSMA PET scan makes it one of the most important developments in the history of prostate cancer management. However, its use in the United States is still not universal for men diagnosed with prostate cancer. Moreover, since the scan has just now become widely available, it could be many years before studies are completed that will determine how, exactly, physicians should interpret and act on the new information it has made available. For example, can a newly diagnosed man with Gleason 8 prostate cancer reduce the duration of hormone therapy if he has a negative PSMA PET scan, or is the negative scan a false sense of security? Here, Dr. Scholz--a medical oncologist specializing in the treatment of prostate cancer--explains how we can think about this information in an era before we have an authoritative, thorough, and scientific understanding of the information and all its implications.
0:07 What are PSMA PET scans and why are they important?
1:23 What is the difference between "PET-CT" and "PSMA PET scan?"
3:38 After treatment, what is the lowest PSA at which the PSMA PET scan would be able to detect the location of the recurrence?
4:17 Other than cost, is there any reason why a person would not have a PSMA PET scan after a prostate cancer diagnosis?
5:05 Does PSMA detect all forms of prostate cancer or does it miss some cancers?
5:58 What is the protocol for avoiding the possibility of having a type of prostate cancer if it does not show up on PSMA PET?
6:28 If cancer shows up on a PSMA PET inside the prostate, what is the negative predictive value of there truly being no metastases?
7:18 Does extracapsular extension mean "locally advanced" prostate cancer?
8:45 Can a PSMA scan be done once hormone therapy has been initiated?
10:15 Can the information from PSMA PET scan help determine the optimal amount of time a patient should spend on hormone therapy?
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #MarkScholzMD #PCRI
https://wn.com/How_Psma_Revolutionizes_Staging_For_Prostatecancer_|_Markscholzmd_|_Pcri
The sensitivity and specificity of the PSMA PET scan makes it one of the most important developments in the history of prostate cancer management. However, its use in the United States is still not universal for men diagnosed with prostate cancer. Moreover, since the scan has just now become widely available, it could be many years before studies are completed that will determine how, exactly, physicians should interpret and act on the new information it has made available. For example, can a newly diagnosed man with Gleason 8 prostate cancer reduce the duration of hormone therapy if he has a negative PSMA PET scan, or is the negative scan a false sense of security? Here, Dr. Scholz--a medical oncologist specializing in the treatment of prostate cancer--explains how we can think about this information in an era before we have an authoritative, thorough, and scientific understanding of the information and all its implications.
0:07 What are PSMA PET scans and why are they important?
1:23 What is the difference between "PET-CT" and "PSMA PET scan?"
3:38 After treatment, what is the lowest PSA at which the PSMA PET scan would be able to detect the location of the recurrence?
4:17 Other than cost, is there any reason why a person would not have a PSMA PET scan after a prostate cancer diagnosis?
5:05 Does PSMA detect all forms of prostate cancer or does it miss some cancers?
5:58 What is the protocol for avoiding the possibility of having a type of prostate cancer if it does not show up on PSMA PET?
6:28 If cancer shows up on a PSMA PET inside the prostate, what is the negative predictive value of there truly being no metastases?
7:18 Does extracapsular extension mean "locally advanced" prostate cancer?
8:45 Can a PSMA scan be done once hormone therapy has been initiated?
10:15 Can the information from PSMA PET scan help determine the optimal amount of time a patient should spend on hormone therapy?
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #MarkScholzMD #PCRI
- published: 09 Jan 2023
- views: 20194
17:08
PSMA/PET Imaging for Prostate Cancer
Welcome to the 2023 ZERO Prostate Cancer Summit! In this segment, hear about PSMA/PET imaging for prostate cancer from Dr. Daneil Kuftinec.
For more informatio...
Welcome to the 2023 ZERO Prostate Cancer Summit! In this segment, hear about PSMA/PET imaging for prostate cancer from Dr. Daneil Kuftinec.
For more information on ZERO Prostate Cancer, visit zerocancer.org.
https://wn.com/Psma_Pet_Imaging_For_Prostate_Cancer
Welcome to the 2023 ZERO Prostate Cancer Summit! In this segment, hear about PSMA/PET imaging for prostate cancer from Dr. Daneil Kuftinec.
For more information on ZERO Prostate Cancer, visit zerocancer.org.
- published: 14 Mar 2023
- views: 13426
6:26
How PSMA Can Change Treatment Decisions for Prostate Cancer | Mark Moyad, MD, MPH & Mark Scholz, MD
Watch the entire 2021 Mid-Year Update here: https://youtu.be/mQzpdvLBeVM
Drs. Mark Scholz and Mark Moyad discuss the implications of the recently approved PSMA...
Watch the entire 2021 Mid-Year Update here: https://youtu.be/mQzpdvLBeVM
Drs. Mark Scholz and Mark Moyad discuss the implications of the recently approved PSMA PET scan in the management of prostate cancer.
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#MarkScholzMD #MarkMoyadMD #ProstateCancer
https://wn.com/How_Psma_Can_Change_Treatment_Decisions_For_Prostate_Cancer_|_Mark_Moyad,_Md,_Mph_Mark_Scholz,_Md
Watch the entire 2021 Mid-Year Update here: https://youtu.be/mQzpdvLBeVM
Drs. Mark Scholz and Mark Moyad discuss the implications of the recently approved PSMA PET scan in the management of prostate cancer.
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#MarkScholzMD #MarkMoyadMD #ProstateCancer
- published: 26 Apr 2021
- views: 22043
32:05
2021: PSMA and Prostate Imaging | Dr. Thomas Hope | 2021 Moyad + Scholz Mid-Year Update | PCRI
Watch the entire 2021 Mid-Year Update here: https://youtu.be/mQzpdvLBeVM
Radiologist and nuclear medicine expert, Thomas Hope, MD gives a survey of the imaging...
Watch the entire 2021 Mid-Year Update here: https://youtu.be/mQzpdvLBeVM
Radiologist and nuclear medicine expert, Thomas Hope, MD gives a survey of the imaging modalities being used in the management of prostate cancer with an emphasis on the PSMA PET scan which was recently FDA-approved thanks in large part to the efforts of Dr. Hope at the University of California, San Francisco.
Thomas Hope, MD, is the Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. He also serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center.
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #PSMA #ThomasHopeMD
https://wn.com/2021_Psma_And_Prostate_Imaging_|_Dr._Thomas_Hope_|_2021_Moyad_Scholz_Mid_Year_Update_|_Pcri
Watch the entire 2021 Mid-Year Update here: https://youtu.be/mQzpdvLBeVM
Radiologist and nuclear medicine expert, Thomas Hope, MD gives a survey of the imaging modalities being used in the management of prostate cancer with an emphasis on the PSMA PET scan which was recently FDA-approved thanks in large part to the efforts of Dr. Hope at the University of California, San Francisco.
Thomas Hope, MD, is the Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. He also serves as Chief of Nuclear Medicine at the San Francisco VA Medical Center.
Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #PSMA #ThomasHopeMD
- published: 02 Apr 2021
- views: 53977
2:15
What is PSMA-PET Scan Radioactive Imaging?
Discover the miracle of PSMA-PET scans. PSMA-PET Scan Radioactive Imaging is the cutting edge in detecting cancer. This video features world-class doctors and r...
Discover the miracle of PSMA-PET scans. PSMA-PET Scan Radioactive Imaging is the cutting edge in detecting cancer. This video features world-class doctors and researchers discussing this amazing cancer detecting scan.
Featuring Thomas Hope, MD, Kenneth J. Pienta, MD, and Neil H. Bander, MD
https://wn.com/What_Is_Psma_Pet_Scan_Radioactive_Imaging
Discover the miracle of PSMA-PET scans. PSMA-PET Scan Radioactive Imaging is the cutting edge in detecting cancer. This video features world-class doctors and researchers discussing this amazing cancer detecting scan.
Featuring Thomas Hope, MD, Kenneth J. Pienta, MD, and Neil H. Bander, MD
- published: 01 Dec 2020
- views: 15632
2:25
Detecting prostate cancer with PSMA PET
A new imaging method called the prostate specific membrane antigen PET scan helps physicians detect more prostate cancer cells so they can be treated. When Davi...
A new imaging method called the prostate specific membrane antigen PET scan helps physicians detect more prostate cancer cells so they can be treated. When David McEowen discovered he had a recurrence of prostate cancer, his physicians used PSMA PET as part of his treatment plan. Today, David is cancer-free.
https://wn.com/Detecting_Prostate_Cancer_With_Psma_Pet
A new imaging method called the prostate specific membrane antigen PET scan helps physicians detect more prostate cancer cells so they can be treated. When David McEowen discovered he had a recurrence of prostate cancer, his physicians used PSMA PET as part of his treatment plan. Today, David is cancer-free.
- published: 01 Dec 2020
- views: 8795